Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

Area of Science:

• Gene Therapy
• Virology
• Molecular Biology

Background:

• Adeno-associated virus (AAV) vectors are crucial for gene therapy, but require improvements for wider use.
• Current AAV vectors face limitations in transduction potency, immune evasion, and cell specificity.

Purpose of the Study:

• To review recent advances in AAV vector biology and capsid engineering.
• To highlight innovations poised to enhance AAV vector performance in gene therapy.

Main Methods:

• Review of recent literature on AAV life cycle, virus-host interactions, and capsid evolution.
• Analysis of novel AAV capsid design strategies and high-throughput screening methods.

Main Results:

• New understanding of AAV life cycle, including autophagy roles and receptor identification.
• Development of engineered AAV capsids with improved immune evasion and assembly.
• Emergence of innovative high-throughput methods for AAV capsid library generation and screening.

Conclusions:

• Recent breakthroughs significantly advance AAV vector technology for gene therapy.
• Combined application of novel insights and engineering strategies promises to overcome current limitations.
• Optimism for the future of AAV-based human gene therapy is substantial.